Muscle Fiber Fragments for Rotator Cuff Injury
Trial Summary
What is the purpose of this trial?
This trial involves injecting small pieces of a patient's own muscle into their shoulder to help strengthen a weakened rotator cuff muscle. The goal is for these muscle pieces to integrate and grow, improving muscle size and function.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
How is the Muscle Fiber Fragments treatment different from other treatments for rotator cuff injury?
Muscle Fiber Fragments (MFFs) treatment is unique because it focuses on enhancing muscle regeneration and reducing fibrosis (thickening and scarring of tissue) and fat accumulation in the muscle, which are common issues in chronic rotator cuff injuries. This approach is different from traditional treatments that may not directly target these specific muscle changes.12345
Research Team
Gary G Poehling, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for men and women aged 40-80 with a rotator cuff tear smaller than 1.5cm, without diabetes, arthritis of the shoulder, autoimmune diseases, certain viral infections (HIV, Hepatitis B/C), or previous shoulder surgeries. Participants must be able to follow post-op instructions and attend follow-up visits.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo rotator cuff repair and receive direct injection of Muscle Fiber Fragments (MFFs) into the supraspinatus muscle
Follow-up
Participants are monitored for safety and effectiveness, including muscle recovery and adverse events
Treatment Details
Interventions
- Muscle Fiber Fragments (MFFs) (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Dr. L. Ebony Boulware
Wake Forest University Health Sciences
Chief Medical Officer since 2022
MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health
Dr. Julie Ann Freischlag
Wake Forest University Health Sciences
Chief Executive Officer since 2020
BS from University of Illinois, MD from Rush University